Top Markets
Coin of the day
QuantRx Biomedical Corporation QuantRx Biomedical Corporation

QuantRx Biomedical Corporation

QTXB
株式のランク #40578
QuantRx Biomedical Corporation is engaged in the creation and marketing of its... QuantRx Biomedical Corporation is engaged in the creation and marketing of its patented miniature pads (PADs) and related over-the-counter (OTC) products within the United States. Additionally, the company is developing genomic diagnostic tools for the laboratory market, leveraging its proprietary lateral flow technologies, including the RapidSense single-step lateral flow test. The company's PAD products are designed to address a range of medical conditions such as hemorrhoids, mild vaginal infections, urinary incontinence, menstrual hygiene, and other general medical needs. Key offerings include InSync, an interlabial pad for feminine hygiene. Another significant product is the Unique miniform, which comes in two forms: a medicated pad providing temporary relief from the itching and discomfort associated with hemorrhoids and minor vaginal infections, and an unmedicated pad for daily management of light urinary, vaginal, or anal leakage. Other treated miniform products are also part of their portfolio. Established in 1986, QuantRx Biomedical Corporation is headquartered in Tualatin, Oregon.
株価
$0.0005
最終同期: 2025-04-08
時価総額
$118.05K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 QuantRx Biomedical Corporation (QTXB)

カテゴリー

QuantRx Biomedical Corporation(QTXB)のEPS
2026 時点のEPS TTM: 0
QuantRx Biomedical Corporationの最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
QuantRx Biomedical CorporationのEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS